This new edition and fully updated publication replaces the 2012 UCG and is being circulated free of charge to all public and private sector prescribers, pharmacists, and regulatory authorities in the country
BMC Medicine201614:112 DOI: 10.1186/s12916-016-0660-0
Introduction
Chapter A.13
Prepared as an outcome of ICMR Subcommittee on Soft Tissue Sarcoma and Osteosarcoma | This consensus document on Management of Soft Tissue Sarcoma and Osteosarcoma summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular ...markers and research questions. It also interweaves clinical, biochemical and epidemiological studies.
more
L’enquête SARA a pour objectif d’évaluer la disponibilité, la capacité opérationnelle des services de santé au Bénin et la qualité des données du Système National d’Informations et de Gestion Sanitaires (SNIGS). Elle a été menée dans 788 formations sanitaires réparties sur toutes... les trente-quatre (34) zones sanitaires et les résultats suivants ont été obtenus
more
The document is intended to facilitate the detection, evaluation and management of incident EVD cases in Germany. It primarily addresses public health service staff and health care workers in hospitals, outpatient clinics and emergency services in Germany. It is a work in progress, intended to evolv...e over time. Updated 14 August 2015
more
Journal of The Association of Physicians of India, Vol. 63 November 2015,, pp.77-96
A quick reference guide for health authorities and health-care workers
Revised 2015
DOI 10.15252/emmm.201404792 |Published online 30.12.2014
EMBO Molecular Medicine(2014)emmm.201404792
Lignes directrices.
Collection Avis et Rapports.